Invasive assessment of coronary microvascular dysfunction and cardiovascular outcomes across the full spectrum of CAD: a meta-analysis

Coronary microvascular dysfunction (CMD) is highly prevalent and is recognized as an important clinical entity in patients with coronary heart disease (CHD). Nevertheless, the association of CMD with adverse cardiovascular events in the spectrum of CHD has not been systemically quantified.